(0.30%) 5 170.25 points
(0.25%) 38 929 points
(0.26%) 18 048 points
(1.13%) $78.99
(0.42%) $2.15
(0.83%) $2 327.70
(2.61%) $27.39
(0.84%) $973.40
(-0.05%) $0.928
(-0.31%) $10.84
(-0.21%) $0.795
(-0.01%) $91.44
-2.68% INR 534.65
Live Chart Being Loaded With Signals
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals...
Stats | |
---|---|
Объем за сегодня | 300 134 |
Средний объем | 858 601 |
Рыночная капитализация | 85.16B |
EPS | INR3.64 ( 2023-11-01 ) |
Last Dividend | INR2.50 ( 2023-08-10 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 41.25 |
ATR14 | INR0.768 (0.14%) |
Объем Корреляция
Jubilant Ingrevia Limited Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Jubilant Ingrevia Limited Корреляция - Валюта/Сырье
Jubilant Ingrevia Limited Финансовые показатели
Annual | 2022 |
Выручка: | INR47.40B |
Валовая прибыль: | INR21.59B (45.54 %) |
EPS: | INR19.34 |
FY | 2022 |
Выручка: | INR47.40B |
Валовая прибыль: | INR21.59B (45.54 %) |
EPS: | INR19.34 |
FY | 2022 |
Выручка: | INR49.14B |
Валовая прибыль: | INR19.56B (39.80 %) |
EPS: | INR29.98 |
FY | 2021 |
Выручка: | INR6.79B |
Валовая прибыль: | INR3.09B (45.51 %) |
EPS: | INR3.41 |
Financial Reports:
No articles found.
Jubilant Ingrevia Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR2.50 (N/A) |
INR0 (N/A) |
INR2.50 (N/A) |
INR0 (N/A) |
INR2.50 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.350 | 2021-08-05 |
Last Dividend | INR2.50 | 2023-08-10 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | INR10.35 | -- |
Avg. Dividend % Per Year | 0.47% | -- |
Score | 1.95 | -- |
Div. Sustainability Score | 2.31 | |
Div.Growth Potential Score | 2.43 | |
Div. Directional Score | 2.37 | -- |
Year | Amount | Yield |
---|---|---|
2021 | INR0.350 | 0.13% |
2022 | INR5.00 | 0.85% |
2023 | INR5.00 | 0.95% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SYMPHONY.NS | Dividend Knight | 2023-08-04 | Semi-Annually | 14 | 0.47% | |
NESCO.NS | Dividend Junior | 2023-07-28 | Annually | 17 | 0.40% | |
IDBI.NS | Dividend Junior | 2023-07-06 | Sporadic | 27 | 0.48% | |
CERA.NS | Dividend Junior | 2023-06-20 | Annually | 17 | 0.39% | |
RVNL.NS | Dividend Knight | 2023-09-20 | Annually | 6 | 3.08% | |
LSIL.NS | Dividend Junior | 2023-07-17 | Annually | 3 | 0.23% | |
GEOJITFSL.NS | Dividend Knight | 2023-06-30 | Annually | 20 | 2.79% | |
ARVIND.NS | Dividend Junior | 2023-07-21 | Sporadic | 20 | 0.59% | |
THEMISMED.NS | Dividend Junior | 2023-08-31 | Sporadic | 18 | 0.39% | |
ORIENTELEC.NS | Dividend Junior | 2023-07-26 | Semi-Annually | 7 | 0.41% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0494 | 1.500 | 9.01 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0768 | 1.500 | -0.258 | -0.387 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 7.33 | 1.000 | 8.40 | 8.40 | [3 - 30] |
operatingCashFlowPerShareTTM | 12.81 | 2.00 | 5.73 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 12.81 | 2.00 | 3.60 | 7.19 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.470 | 1.000 | 5.51 | 5.51 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0787 | 1.000 | -0.426 | -0.426 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.31 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 41.04 | 1.000 | 5.96 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0768 | 2.50 | -0.166 | -0.387 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 12.81 | 2.00 | 5.73 | 7.19 | [0 - 30] |
dividendYielPercentageTTM | 0.940 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 12.81 | 2.00 | 5.73 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -1.156 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0488 | 1.000 | -1.279 | 0 | [0.1 - 0.5] |
Total Score | 2.43 |
Jubilant Ingrevia Limited
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа